As aforementioned, EpCAM is commonly observed to be upregulated in various primary tumour types and metastases, particularly on adenocarcinoma, certain squamous cell carcinoma and retinoblastoma [5,62]. Here, EPCAM is linked to squamous cell carcinoma.